This is a 2-part, prospective, randomized, blinded, sham-controlled, multi-center study comparing preterm subjects with RDS who are treated with APC-0101 and nCPAP/NIV to subjects treated with nCPAP/NIV alone (Sham). In Part 1, subjects will be followed until they reach 40 weeks post-menstrual age (PMA) or are discharged from the NICU, whichever comes first. In Part 2, subjects will undergo post-term follow-up through 24 months corrected age.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
520
Subjects in the APC-0101 group will be changed from their current nCPAP/NIV interface to the APC-0101 nCPAP/NIV interface and APC-0101 treatment will be started.
Subjects in the Control group will be changed from their current nCPAP/NIV interface to the APC-0101 nCPAP/NIV interface but an empty vial will be used instead of APC-0101.
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
RECRUITINGJacobs Medical Center
La Jolla, California, United States
RECRUITINGUF Health Jacksonville
Jacksonville, Florida, United States
RECRUITINGAdvent Health
Orlando, Florida, United States
RECRUITINGMemorial Hospital of South Bend
South Bend, Indiana, United States
RECRUITINGGoryeb Children's Hospital
Morristown, New Jersey, United States
RECRUITINGThe Trustees of Columbia University in the City of New York
New York, New York, United States
RECRUITINGMontefiore Medical Center
The Bronx, New York, United States
RECRUITINGMaria Farreri Children's Hospital
Valhalla, New York, United States
RECRUITINGChristus Children's Hospital
San Antonio, Texas, United States
RECRUITING...and 2 more locations
Failure Criteria
Number (%) of subjects who meet the predetermined criteria for failure of nCPAP/NIV
Time frame: First 7 days of life
Instilled Bolus Surfactant
The number (%) of subjects in each group who receive instilled bolus surfactant.
Time frame: First 72 hours of life
Multiple Bolus Surfactant Doses
The number (%) of subjects in each group who receive multiple doses of bolus surfactant.
Time frame: First 72 hours of life
Total Number of Bolus Surfactant Doses
The total number of bolus doses of surfactant received per subject in each group.
Time frame: First 72 hours of life
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.